1.
Clarke C, Howard R, Rossor M, Shorvon SD, editors. Neurology: a Queen Square textbook [Internet]. Second edition. Chichester, West Sussex, UK: Wiley Blackwell; 2016. Available from: https://onlinelibrary.wiley.com/doi/book/10.1002/9781118486160
2.
McCarthy RA, Warrington EK. Cognitive neuropsychology: a clinical introduction [Internet]. San Diego, California: Academic Press, Inc; 1990. Available from: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=2909618430004761&institutionId=4761&customerId=4760
3.
Rossor M, Growdon JH. The dementias 2 [Internet]. [Place of publication not identified]: Butterworth Heinemann/Elsevier; 2007. Available from: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=2909618250004761&institutionId=4761&customerId=4760
4.
Hodges JR. Cognitive assessment for clinicians [Internet]. 3 ed. [Oxford]: Oxford University Press; 2017. Available from: http://dx.doi.org/10.1093/med/9780198749189.001.0001
5.
Kandel ER, Schwartz JH, Jessell TM, Siegelbaum S, Hudspeth AJ, editors. Principles of neural science [Internet]. Fifth edition. New York: McGraw Hill Medical; 2013. Available from: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=2909605810004761&institutionId=4761&customerId=4760
6.
Husain M. Oxford textbook of cognitive neurology and dementia [Internet]. Husain M, Schott JM, Kennard C, editors. [Oxford]: Oxford University Press; 2016. Available from: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=2909605720004761&institutionId=4761&customerId=4760
7.
Alzheimer’s Facts and Figures Report | Alzheimer’s Association [Internet]. Available from: https://www.alz.org/alzheimers-dementia/facts-figures
8.
Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Molecular Medicine. 2016 Jun;8(6):595–608.
9.
Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. The Lancet Neurology. 2014 Jun;13(6):614–629.
10.
Loy CT, Schofield PR, Turner AM, Kwok JB. Genetics of dementia. The Lancet. 2014 Mar;383(9919):828–840.
11.
Karran E, Hardy J. Antiamyloid Therapy for Alzheimer’s Disease — Are We on the Right Road? New England Journal of Medicine. 2014 Jan 23;370(4):377–378.
12.
Johnson KA, Fox NC, Sperling RA, Klunk WE. Brain Imaging in Alzheimer Disease. Cold Spring Harbor Perspectives in Medicine. 2012 Apr 1;2(4):a006213–a006213.
13.
Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology. 2014 Apr;10(4):204–216.
14.
Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ. Huntington disease. Nature Reviews Disease Primers. 2015 Apr 23;
15.
Wild EJ, Tabrizi SJ. Therapies targeting DNA and RNA in Huntington’s disease. The Lancet Neurology. 2017 Oct;16(10):837–847.
16.
Carroll JB, Bates GP, Steffan J, Saft C, Tabrizi SJ. Treating the whole body in Huntington’s disease. The Lancet Neurology. 2015 Nov;14(11):1135–1142.
17.
Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC. Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: the 12-month longitudinal analysis. The Lancet Neurology. 2011 Jan;10(1):31–42.
18.
Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR. Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: analysis of 24 month observational data. The Lancet Neurology. 2012 Jan;11(1):42–53.
19.
Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data. The Lancet Neurology. 2013 Jul;12(7):637–649.
20.
Jones L, Houlden H, Tabrizi SJ. DNA repair in the trinucleotide repeat disorders. The Lancet Neurology. 2017 Jan;16(1):88–96.
21.
Rossor M, Collinge J, Fox N, Mead S, Mummery C, Rohrer J, Schott J, Warren J. Dementia and Cognitive Impairment. In: Clarke C, Howard R, Rossor M, Shorvon S, editors. Neurology [Internet]. Chichester, UK: John Wiley & Sons, Ltd; 2016. p. 289–336. Available from: http://doi.wiley.com/10.1002/9781118486160.ch8
22.
Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The diagnosis of young-onset dementia. The Lancet Neurology. 2010 Aug;9(8):793–806.
23.
Schott JM, Fox NC, Rossor MN. Assessment and investigation of the cognitively impaired adult. In: Husain M, Schott JM, editors. Oxford Textbook of Cognitive Neurology and Dementia [Internet]. Oxford University Press; 2016. p. 221–230. Available from: http://oxfordmedicine.com/view/10.1093/med/9780199655946.001.0001/med-9780199655946-chapter-21
24.
Green AJE. RT-QuIC: a new test for sporadic CJD. Practical Neurology. 2018 Oct 3;
25.
Collinge J. Mammalian prions and their wider relevance in neurodegenerative diseases. Nature. 2016 Nov 9;539(7628):217–226.
26.
Mead S, Rudge P. CJD mimics and chameleons. Practical Neurology. 2017 Apr;17(2):113–121.
27.
Walker Z, Possin KL, Boeve BF, Aarsland D. Lewy body dementias. The Lancet. 2015 Oct;386(10004):1683–1697.
28.
Halliday GM, Holton JL, Revesz T, Dickson DW. Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathologica. 2011 Aug;122(2):187–204.
29.
Barker RA, Williams-Gray CH. Review: The spectrum of clinical features seen with alpha synuclein pathology. Neuropathology and Applied Neurobiology. 2016 Feb;42(1):6–19.
30.
Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns N, Halliday GM, Mann D, Pickering-Brown S, Dickson DW, Singleton A, Hardy J. Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Human Molecular Genetics. 2014 Dec 1;23(23):6139–6146.
31.
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O’Brien JT, Orimo S, Postuma RB. Diagnosis and management of dementia with Lewy bodies. Neurology. 2017 Jul 4;89(1):88–100.
32.
Weil RS, Lashley TL, Bras J, Schrag AE, Schott JM. Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies. F1000Research. 2017 Aug 30;6.
33.
Woollacott IOC, Rohrer JD. The clinical spectrum of sporadic and familial forms of frontotemporal dementia. Journal of Neurochemistry. 2016 Aug;138:6–31.
34.
Gordon E, Rohrer JD, Fox NC. Advances in neuroimaging in frontotemporal dementia. Journal of Neurochemistry. 2016 Aug;138:193–210.
35.
Ahmed RM, Devenney EM, Irish M, Ittner A, Naismith S, Ittner LM, Rohrer JD, Halliday GM, Eisen A, Hodges JR, Kiernan MC. Neuronal network disintegration: common pathways linking neurodegenerative diseases. Journal of Neurology, Neurosurgery & Psychiatry. 2016 Nov;87(11):1234–1241.
36.
Fletcher PD, Warren JD. Semantic Dementia: a specific network-opathy. Journal of Molecular Neuroscience. 2011 Nov;45(3):629–636.
37.
Goll JC, Crutch SJ, Loo JHY, Rohrer JD, Frost C, Bamiou DE, Warren JD. Non-verbal sound processing in the primary progressive aphasias. Brain. 2010 Jan;133(1):272–285.
38.
Goll JC, Ridgway GR, Crutch SJ, Theunissen FE, Warren JD. Nonverbal sound processing in semantic dementia: A functional MRI study. NeuroImage. 2012 May;61(1):170–180.
39.
Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M. Classification of primary progressive aphasia and its variants. Neurology. 2011 Mar 15;76(11):1006–1014.
40.
Grossman M. The non-fluent/agrammatic variant of primary progressive aphasia. The Lancet Neurology. 2012 Jun;11(6):545–555.
41.
Leyton CE, Hodges JR, McLean CA, Kril JJ, Piguet O, Ballard KJ. Is the logopenic-variant of primary progressive aphasia a unitary disorder? Cortex. 2015 Jun;67:122–133.
42.
Marshall CR, Hardy CJD, Volkmer A, Russell LL, Bond RL, Fletcher PD, Clark CN, Mummery CJ, Schott JM, Rossor MN, Fox NC, Crutch SJ, Rohrer JD, Warren JD. Primary progressive aphasia: a clinical approach. Journal of Neurology. 2018 Jun;265(6):1474–1490.
43.
Rohrer JD, Knight WD, Warren JE, Fox NC, Rossor MN, Warren JD. Word-finding difficulty: a clinical analysis of the progressive aphasias. Brain. 2007 Dec 3;131(1):8–38.
44.
Rohrer JD, Ridgway GR, Crutch SJ, Hailstone J, Goll JC, Clarkson MJ, Mead S, Beck J, Mummery C, Ourselin S, Warrington EK, Rossor MN, Warren JD. Progressive logopenic/phonological aphasia: Erosion of the language network. NeuroImage. 2010 Jan;49(1):984–993.
45.
Rohrer JD, Rossor MN, Warren JD. Syndromes of nonfluent primary progressive aphasia: A clinical and neurolinguistic analysis. Neurology. 2010 Aug 17;75(7):603–610.
46.
Rohrer JD, Sauter D, Scott S, Rossor MN, Warren JD. Receptive prosody in nonfluent primary progressive aphasias. Cortex. 2012 Mar;48(3):308–316.
47.
Warren JD, Rohrer JD, Rossor MN. Frontotemporal dementia. BMJ. 2013 Aug 20;347(aug12 3):f4827–f4827.
48.
Lynch DS, Rodrigues Brandão de Paiva A, Zhang WJ, Bugiardini E, Freua F, Tavares Lucato L, Macedo-Souza LI, Lakshmanan R, Kinsella JA, Merwick A, Rossor AM, Bajaj N, Herron B, McMonagle P, Morrison PJ, Hughes D, Pittman A, Laurà M, Reilly MM, Warren JD, Mummery CJ, Schott JM, Adams M, Fox NC, Murphy E, Davagnanam I, Kok F, Chataway J, Houlden H. Clinical and genetic characterization of leukoencephalopathies in adults. Brain. 2017 May 1;140(5):1204–1211.
49.
Hollak CEM, Lachmann R, editors. Inherited metabolic disease in adults: a clinical guide [Internet]. [New York]: Oxford University Press; 2016. Available from: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=3043210560004761&institutionId=4761&customerId=4760
50.
Devenney E, Vucic S, Hodges JR, Kiernan MC. Motor neuron disease-frontotemporal dementia: a clinical continuum. Expert Review of Neurotherapeutics. 2015 May 4;15(5):509–522.
51.
Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, Mioshi E, Roberts-South A, Benatar M, HortobáGyi T, Rosenfeld J, Silani V, Ince PG, Turner MR. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2017 Apr 3;18(3–4):153–174.
52.
Iranzo A, Fernández-Arcos A, Tolosa E, Serradell M, Molinuevo JL, Valldeoriola F, Gelpi E, Vilaseca I, Sánchez-Valle R, Lladó A, Gaig C, Santamaría J. Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients. PLoS ONE. 2014 Feb 26;9(2).
53.
Kielb SA, Ancoli-Israel S, Rebok GW, Spira AP. Cognition in Obstructive Sleep Apnea-Hypopnea Syndrome (OSAS): Current Clinical Knowledge and the Impact of Treatment. NeuroMolecular Medicine. 2012 Sep;14(3):180–193.
54.
Mander BA, Winer JR, Jagust WJ, Walker MP. Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer’s Disease? Trends in Neurosciences. 2016 Aug;39(8):552–566.
55.
McCarter SJ, St. Louis EK, Boeve BF. Sleep Disturbances in Frontotemporal Dementia. Current Neurology and Neuroscience Reports. 2016 Sep;16(9).
56.
Ooms S, Ju YE. Treatment of Sleep Disorders in Dementia. Current Treatment Options in Neurology. 2016 Sep;18(9).
57.
Hardy CJD, Marshall CR, Golden HL, Clark CN, Mummery CJ, Griffiths TD, Bamiou DE, Warren JD. Hearing and dementia. Journal of Neurology. 2016 Nov;263(11):2339–2354.
58.
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, Cooper C, Fox N, Gitlin LN, Howard R, Kales HC, Larson EB, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N. Dementia prevention, intervention, and care. The Lancet. 2017 Dec;390(10113):2673–2734.
59.
Goll JC, Crutch SJ, Warren JD. Central auditory disorders: toward a neuropsychology of auditory objects. Current Opinion in Neurology. 2010 Dec;23(6):617–627.
60.
Husain M. Oxford textbook of cognitive neurology and dementia [Internet]. Husain M, Schott JM, Kennard C, editors. [Oxford]: Oxford University Press; 2016. Available from: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=3119511110004761&institutionId=4761&customerId=4760
61.
Blennow K, Hardy J, Zetterberg H. The Neuropathology and Neurobiology of Traumatic Brain Injury. Neuron. 2012 Dec;76(5):886–899.
62.
Smith DH, Johnson VE, Stewart W. Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nature Reviews Neurology. 2013 Apr;9(4):211–221.
63.
McKee AC, Stein TD, Nowinski CJ, Stern RA, Daneshvar DH, Alvarez VE, Lee HS, Hall G, Wojtowicz SM, Baugh CM, Riley DO, Kubilus CA, Cormier KA, Jacobs MA, Martin BR, Abraham CR, Ikezu T, Reichard RR, Wolozin BL, Budson AE, Goldstein LE, Kowall NW, Cantu RC. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013 Jan;136(1):43–64.
64.
Fleminger S. Head injury as a risk factor for Alzheimer’s disease: the evidence 10 years on; a partial replication. Journal of Neurology, Neurosurgery & Psychiatry. 2003 Jul 1;74(7):857–862.
65.
Scott G, Ramlackhansingh AF, Edison P, Hellyer P, Cole J, Veronese M, Leech R, Greenwood RJ, Turkheimer FE, Gentleman SM, Heckemann RA, Matthews PM, Brooks DJ, Sharp DJ. Amyloid pathology and axonal injury after brain trauma. Neurology. 2016 Mar 1;86(9):821–828.
66.
Hereditary and sporadic beta-amyloidoses [Internet]. Available from: https://www.bioscience.org/2013/v18/af/4173/fulltext.htm
67.
Johnson GVW. Tau phosphorylation in neuronal cell function and dysfunction. Journal of Cell Science. 2004 Nov 15;117(24):5721–5729.
68.
Revesz T, Holton JL, Lashley T, Plant G, Frangione B, Rostagno A, Ghiso J. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathologica. 2009 Jul;118(1):115–130.
69.
Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathologica. 2012 Jan;123(1):1–11.
70.
Thal DR. Neurodegeneration in Normal Brain Aging and Disease. Science of Aging Knowledge Environment. 2004 Jun 9;2004(23):pe26–pe26.
71.
Braak H, Braak E. Staging of alzheimer’s disease-related neurofibrillary changes. Neurobiology of Aging. 1995 May;16(3):271–278.
72.
Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G v., Berg L. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology. 1991 Apr 1;41(4):479–479.
73.
Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathologica. 2012 Jan;123(1):1–11.
74.
Dobson R, Alvares D. The difficulties with vitamin B. Practical Neurology. 2016 Aug;16(4):308–311.
75.
Jonathan Carr. Neurosyphilis. Practical Neurology [Internet]. BMJ Publishing Group Ltd; 2003 Dec 1;3:328–341. Available from: https://pn.bmj.com/content/3/6/328
76.
Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology. 2016 Apr;15(4):391–404.
77.
Salvarani C, Brown RD, Hunder GG. Adult primary central nervous system vasculitis. The Lancet. 2012 Aug;380(9843):767–777.
78.
Halperin JJ, Kurlan R, Schwalb JM, Cusimano MD, Gronseth G, Gloss D. Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response. Neurology. 2015 Dec 8;85(23):2063–2071.
79.
Arash Asher. The effect of cancer treatment on cognitive function. undefined [Internet]. Available from: https://www.semanticscholar.org/paper/The-effect-of-cancer-treatment-on-cognitive-Asher-Myers/6bdd550dab6cfad0714aa76dd2ee439ad983e4be
80.
Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology. 2016 Apr;15(4):391–404.
81.
Cognitive Impairment Associated with Cancer: A Brief Review. Innovations in Clinical Neuroscience [Internet]. Matrix Medical Communications; 2018;15(1–2). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819720/
82.
Haddow LJ, Cartledge JD, Manji H. HIV and the brain: from AIDS to old age. Clinical Medicine. 2013 Dec 1;13(Suppl_6):s24–s28.
83.
Nightingale S, Michael BD, Defres S, Benjamin LA, Solomon T. Test them all; an easily diagnosed and readily treatable cause of dementia with life-threatening consequences if missed. Practical Neurology. 2013 Dec;13(6):354–356.
84.
HIV in the United Kingdom 2016 infographic [Internet]. Available from: https://www.gov.uk/government/publications/hiv-in-the-united-kingdom
85.
Itzhaki RF, Lathe R, Balin BJ, Ball MJ, Bearer EL, Braak H, Bullido MJ, Carter C, Clerici M, Cosby SL, Del Tredici K, Field H, Fulop T, Grassi C, Griffin WST, Haas J, Hudson AP, Kamer AR, Kell DB, Licastro F, Letenneur L, Lövheim H, Mancuso R, Miklossy J, Otth C, Palamara AT, Perry G, Preston C, Pretorius E, Strandberg T, Tabet N, Taylor-Robinson SD, Whittum-Hudson JA. Microbes and Alzheimer’s Disease. Journal of Alzheimer’s Disease. 2016 Apr 12;51(4):979–984.
86.
Nightingale S, Winston A, Letendre S, Michael BD, McArthur JC, Khoo S, Solomon T. Controversies in HIV-associated neurocognitive disorders. The Lancet Neurology. 2014 Nov;13(11):1139–1151.
87.
Richard W. Price and Bruce J. Brew. The AIDS Dementia Complex. The Journal of Infectious Diseases [Internet]. Oxford University Press; 1988;158(5). Available from: https://www.jstor.org/stable/30136610?seq=1#metadata_info_tab_contents
88.
UK National Guidelines for HIV Testing 2008 [Internet]. Available from: https://www.bhiva.org/HIV-testing-guidelines
89.
Zhou L, Miranda-Saksena M, Saksena NK. Viruses and neurodegeneration. Virology Journal. 2013;10(1).
90.
De Chiara G, Marcocci ME, Sgarbanti R, Civitelli L, Ripoli C, Piacentini R, Garaci E, Grassi C, Palamara AT. Infectious Agents and Neurodegeneration. Molecular Neurobiology. 2012 Dec;46(3):614–638.
91.
Wendorf KA, Winter K, Zipprich J, Schechter R, Hacker JK, Preas C, Cherry JD, Glaser C, Harriman K. Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated. Clinical Infectious Diseases. 2017 Jul 15;65(2):226–232.
92.
Ghanem KG. REVIEW: Neurosyphilis: A Historical Perspective and Review. CNS Neuroscience & Therapeutics. 2010 Oct;16(5):e157–e168.
93.
Somasundaram O. Neuro syphilis: Portrayals by Sir Arthur Conan Doyle. Indian Journal of Psychiatry. 2009;51(3).
94.
Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG. National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards. Stroke. 2006 Sep;37(9):2220–2241.
95.
Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S. Vascular Contributions to Cognitive Impairment and Dementia. Stroke. 2011 Sep;42(9):2672–2713.
96.
Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. The Lancet. 2001 Jan;357(9251):169–175.
97.
Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. The Lancet Neurology. 2005 Nov;4(11):752–759.
98.
O’Brien JT, Thomas A. Vascular dementia. The Lancet. 2015 Oct;386(10004):1698–1706.
